Related Experiment Video
Updated: Oct 8, 2025

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
Published on: May 9, 2025
Targeting the RNA-Binding Protein QKI in Myeloid Cells Ameliorates Macrophage-Induced Renal Interstitial Fibrosis
Ruben G de Bruin1,2, Gillian Vogel2, Jurrien Prins1
1Einthoven Laboratory for Experimental Vascular Medicine, Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Albinusdreef 2, C7-36, PO Box 9600, 2300RC Leiden, The Netherlands.
Abstract:
In the pathophysiologic setting of acute and chronic kidney injury, the excessive activation and recruitment of blood-borne monocytes prompts their differentiation into inflammatory macrophages, a process that leads to progressive glomerulosclerosis and interstitial fibrosis. Importantly, this differentiation of monocytes into macrophages requires the meticulous coordination of gene expression at both the transcriptional and post-transcriptional level. The transcriptomes of these cells are ultimately determined by RNA-binding proteins such as QUAKING (QKI), that define their pre-mRNA splicing and mRNA transcript patterns. Using two mouse models, namely (1) quaking viable mice (qk) and (2) the conditional deletion in the myeloid cell lineage using the lysozyme 2-Cre (QKI mice), we demonstrate that the abrogation of QKI expression in the myeloid cell lineage reduces macrophage infiltration following kidney injury induced by unilateral urethral obstruction (UUO). The qk and QKI mice both showed significant diminished interstitial collagen deposition and fibrosis in the UUO-damaged kidney, as compared to wild-type littermates. We show that macrophages isolated from QKI mice are associated with defects in pre-mRNA splicing. Our findings demonstrate that reduced expression of the alternative splice regulator QKI in the cells of myeloid lineage attenuates renal interstitial fibrosis, suggesting that inhibition of this splice regulator may be of therapeutic value for certain kidney diseases.
Insights
Reducing QUAKING (QKI) in myeloid cells lessens kidney fibrosis. This RNA-binding protein regulates gene expression, and its inhibition may offer new therapies for kidney diseases.
Area of Science:
- Molecular Biology
- Renal Pathophysiology
- Immunology
Background:
- Monocyte-derived macrophages drive kidney fibrosis in acute and chronic kidney injury.
- Macrophage differentiation and function are regulated by RNA-binding proteins, including QUAKING (QKI).
- QKI influences gene expression through pre-mRNA splicing and mRNA transcript patterns.
Purpose of the Study:
- To investigate the role of QKI in myeloid cells during kidney injury.
- To determine if abrogating QKI expression in myeloid cells attenuates renal interstitial fibrosis.
Main Methods:
- Utilized two mouse models: quaking viable (qk) mice and myeloid lineage-specific QKI conditional knockout (QKI mice).
- Induced kidney injury using unilateral urethral obstruction (UUO) model.
- Assessed macrophage infiltration, interstitial collagen deposition, and pre-mRNA splicing defects.
Main Results:
- Abrogation of QKI in myeloid cells reduced macrophage infiltration in UUO-induced kidney injury.
- Both qk and QKI mice exhibited significantly diminished interstitial collagen deposition and fibrosis compared to wild-type.
- Macrophages from QKI mice displayed pre-mRNA splicing defects.
Conclusions:
- Reduced QKI expression in myeloid lineage cells attenuates renal interstitial fibrosis.
- QKI is a critical regulator of splicing in macrophages impacting kidney fibrosis.
- Inhibiting QKI may represent a potential therapeutic strategy for fibrotic kidney diseases.

